tags

On August 6, 2026, China NIFDC publicly solicited comments on nine cosmetic standards invloving eight cosmetic ingredients and one testing method in STSC.

Cosmetic efficacy testing has become an essential step in developing compliant, evidence-based cosmetic products. Whether launching a new skincare product, validating sunscreen SPF claims, or supporting anti-ageing marketing claims, brands increasingly need scientific evidence to demonstrate that their products deliver the benefits promised on the label. Consumers today expect greater transparency from cosmetic brands, while regulators worldwide are placing increasing emphasis on ensuring that cosmetic claims are truthful, substantiated, and supported by appropriate evidence. As a result, cosmetic efficacy testing plays a critical role in product development, regulatory compliance, and successful market access.

CIRS Group has compiled and summarized the latest global cosmetic regulatory developments of June 2026.

Technical Summary Based on the Latest OECD Guideline No. 497.

CIRS Group has compiled the sampling-inspection data and typical violations in June to help enterprises keep abreast of market-supervision trends and identify compliance risks.

Not all cosmetic test reports are created equal: some are rejected by regulators, and some aren’t internationally recognized. Choosing the wrong laboratory can delay your product launch or even block market entry entirely. This article explains the differences between CMA, CNAS, and ISO 17025 accreditation, why they matter for cosmetic testing in China, and how to select the right lab for regulatory compliance.

On June 10, 2026, South Korea MFDS published the "Guide for Preparation of Cosmetic Safety Assessment Documentation" , providing guidance for cosmetic responsible distributors on preparing safety assessment documentation.

On May 29, 2026, China’s National Medical Products Administration (NMPA) released eight testing methods to be incorporated into the corresponding chapters of the Safety and Technical Standards for Cosmetics (2015 Edition).

CIRS will be exhibiting at the China Beauty Expo, taking place in Shanghai, China, between May 12-14, 2026.

In March 2026, the Shanghai Municipal, Fujian Provincial, Hubei Provincial, and Anhui Provincial Medical Products Administrations successively issued announcements regarding cosmetic supervision and sampling inspections. A total of 12 batches of products were found to be non-compliant. This summary of the announcements aims to help enterprises stay informed of evolving regulatory trends and strengthen their quality management and compliance awareness.